That high demand is contributing to a manufacturing shortage
Xia J, Huang X, Sun L, Zhu H, Lin W, Dong X, et al
These findings occurred even before there was significant weight loss among participants in the semaglutide group and even before participants had reached the full dose of semaglutide.
Carries a small but real risk of progression to squamous cell carcinoma Leukoplakia white patches on the lip mucosa
Important Safety Information for GLP-1 Treatments Compounded medications are legally prescribed under federal law but are not FDA-approved and have not undergone FDA review for safety, effectiveness, or manufacturing quality
Short telomeres are a risk factor for idiopathic pulmonary fibrosis